OnabotulinumtoxinA in the treatment of refractory chronic cluster headache

OnabotulinumtoxinA in the treatment of refractory chronic cluster headache

Abstract Background Cluster headache (CH) is a clinically well-defined primary headache disorder, approximately 20% of cluster headache sufferers experience recurrent attacks without periods of significant remission. For the treatment of chronic cluster headache (CCH) only limited therapeutic option...

Full description

Bibliographic Details
Main Authors: Christian Lampl, Mirjam Rudolph, Elisabeth Bräutigam
Format: Article
Language:English
Published: BMC 2018-06-01
Series:The Journal of Headache and Pain
Subjects:
Headache
Cluster headache
Refractoriness
Onabotulinumtoxin a
Prophylactic treatment
Online Access:http://link.springer.com/article/10.1186/s10194-018-0874-y

Internet

http://link.springer.com/article/10.1186/s10194-018-0874-y

Similar Items